Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium oxide for hot flashes in breast cancer survivors
NCT01439945Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Sep 2011
- Primary completion
- Aug 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of magnesium oxide in hot flashes, sponsored by Cancer and Leukemia Group B. Started Sep 2011; status: completed.
02
Drugs
magnesium oxide
03
Conditions
hot flashes
Beyond the preview
Go deeper on NCT01439945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439945.